Loading...
Cibus, Inc.
CBUS•NASDAQ
HealthcareBiotechnology
$2.62
$0.46(21.30%)
Cibus, Inc. (CBUS) Stock Overview
Explore Cibus, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
134.56%
↑ 134.56%
Profit Growth
$-0.01
↑ 6.07%
EPS Growth
$-0.01
↑ 99.96%
Operating Margin
-5925.36%
↑ 18.97%
ROE
-203.18%
↑ 6.07%
Dividend Yield
0.00%
Analyst Recommendations
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Price Targets
Low$21.00
Average$22.67
High$25.00
Company Profile
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
CEO
Dr. Peter R. Beetham B.Sc., Ph.D.
Employees
157
Headquarters
6455 Nancy Ridge Drive, San Diego, CA
Founded
2017